Gene Regulation

Gene Regulation — Overview

Part 1 of 7

Every cell in your body — a neuron, a hepatocyte, a B lymphocyte — carries the same complete genome. A liver cell and a skin cell contain identical DNA, yet they look and behave nothing alike. How? They express different subsets of their genes. This is the central puzzle of gene regulation: not which genes an organism has, but which genes are turned on, where, when, and how strongly.

Differential gene expression is the source of cell differentiation in multicellular organisms and of metabolic flexibility in single-celled ones. A muscle cell transcribes actin and myosin genes heavily and keeps insulin genes silent; a pancreatic $\beta$-cell does the reverse. The genome is the same — the regulatory state differs.

Big Idea (AP): Information stored in DNA is not expressed uniformly. Cells regulate gene expression in response to internal signals and the external environment, and this regulation produces the diversity of cell types and the ability to respond to change. (AP Bio EU IST-2)

Levels of Control: Where Can a Cell Intervene?

The path from a gene to a functional protein is long, and the cell can throttle flow at every step. Each control point is an opportunity to tune how much of a protein gets made.

Transcriptional control is the most common and most energy-efficient point of regulation: if a cell never makes the mRNA, it spends nothing on processing, translating, or degrading a protein it does not need. Most of this unit focuses on transcriptional control, but keep the full menu in mind — AP loves asking which level a given experiment is probing.

Logic check: A drug that prevents an mRNA from being translated but leaves its abundance unchanged is acting at the translational level, not the transcriptional level. A Northern blot (which measures mRNA) would look normal; a Western blot (which measures protein) would show a drop.

Constitutive vs. Regulated Genes; Cis vs. Trans

Constitutive genes ("housekeeping genes") are expressed continuously at a roughly steady level because their products are always needed — ribosomal proteins, glycolytic enzymes, tubulin. Regulated genes are switched on or off, or tuned up and down, in response to signals: a digestive enzyme made only when its substrate is present, a heat-shock protein induced only by stress.

To regulate transcription, two categories of player work together:

• Cis-regulatory elements are DNA sequences — they sit on the same molecule as the gene they control (promoters, operators, enhancers, silencers). "Cis" = "on the same side." A cis-element only affects the gene physically linked to it.
• Trans-acting factors are diffusible molecules (almost always proteins — transcription factors, repressors, activators) that are made elsewhere, float through the cell, and bind cis-elements. "Trans" = "across." A trans-factor can act on any matching DNA site in the cell.

This distinction is the single most tested concept in operon genetics (Part 6). A mutation in a cis-element affects only the copy of the gene it is attached to; a mutation in a trans-factor's gene affects every target the factor would normally bind, because the broken (or hyperactive) protein diffuses everywhere.

The central idea: Regulation determines which proteins a cell makes and how much of each. Transcription factors (trans) read the cell's signals and bind regulatory DNA (cis) to set each gene's output. Differentiation, development, and homeostasis all reduce to this read-and-respond logic.

Checkpoint — Levels of Control & Cis/Trans

Prokaryotic vs. Eukaryotic Regulation: The Big Contrast

Bacteria and eukaryotes solve the same problem — making the right proteins at the right time — but with strikingly different architectures. This table previews the rest of the unit; Parts 2-5 fill in the mechanisms.

The deepest structural difference: because eukaryotes wrap DNA around histones to form chromatin, a eukaryotic gene must first be made physically accessible before it can be transcribed. Prokaryotes skip that gatekeeping layer. And because prokaryotes transcribe and translate in the same compartment at the same time, they can respond to a changing meal in seconds — which is exactly what the lac operon (Part 2) does.

AP trap to bank now: Operons are a prokaryotic feature. If an AP question describes a eukaryotic gene "in an operon," it is wrong by definition. Eukaryotic genes are switched on and off one at a time by combinations of transcription factors.

The Read-and-Respond Logic — A Worked Example

Gene regulation is fundamentally a signal-response loop: the cell detects a condition, and a regulatory protein translates that condition into a change in gene output. Trace the logic with a generic example before meeting the real systems in Parts 2-5.

Scenario. A bacterium encounters a new sugar in its environment. It should build the enzyme that digests that sugar — but only now, while the sugar is present. Walk the steps:

1. Signal: the sugar (or a derivative) appears in the cytoplasm.
2. Sensor/transducer: a regulatory protein (a trans-acting factor) changes shape when it binds the signal molecule. This allosteric change is the heart of the response — the protein's DNA-binding behavior flips.
3. DNA target: the altered protein binds (or releases) a cis-regulatory sequence near the enzyme's gene.
4. Output: RNA polymerase is now allowed (or blocked) at the promoter; the enzyme's gene is transcribed (or not); the right amount of enzyme is produced.
5. Feedback: as the sugar is consumed, the signal fades, the regulatory protein reverts, and expression returns to baseline.

Notice what this loop accomplishes: the genome never changes, yet the output of one gene tracks the environment moment-to-moment. This is the entire conceptual content of gene regulation, scaled up: many such loops, layered at the levels in the table above, let a single genome run a bacterium responding to its meal or a human cell committing to becoming a neuron.

Why "how much," not just "on/off." Real regulation is rarely a clean switch. A gene can be expressed at high, medium, low, or trace levels, and cells routinely tune output by combining a strong/weak promoter, the number of bound activators, mRNA stability, and translation rate. When you analyze data, expect fold-changes — "expression rose roughly $5\times$" — rather than absolute presence/absence.

Frame for the whole unit: Every mechanism ahead — operons, enhancers, methylation, miRNAs — is a variation on the same theme: a sensor reads a condition and sets gene output accordingly. Keep asking, for any system: What is the signal? What protein senses it? What DNA or RNA does it act on? Does output go up or down?

Exit Ticket — Part 1 Synthesis

Prokaryotic Regulation — Operons

Part 2 of 7

Bacteria live in volatile environments. E. coli in your gut may be bathed in glucose one minute and switched to lactose the next. Making enzymes is expensive, so a bacterium should build a sugar-digesting enzyme only when that sugar is present and only when no better fuel is available. The operon is the elegant solution.

An operon is a cluster of functionally related genes controlled as a single unit. Its anatomy:

Because the structural genes share one promoter and one operator, they are transcribed into a single polycistronic mRNA and switched on or off together. A regulatory gene (often nearby) encodes the trans-acting protein — a repressor or activator — that reads the cell's signals.

Key distinction (preview): The lac operon is inducible (normally OFF, switched ON by a signal). The trp operon is repressible (normally ON, switched OFF by a signal). Knowing which is which is a perennial AP trap.

The lac Operon I — Negative Control (the LacI Repressor)

The lac operon encodes the enzymes that import and digest lactose, including lacZ ($\beta$-galactosidase, which cleaves lactose into glucose + galactose) and lacY (lactose permease). It is inducible: by default it is OFF, because most of the time there is no lactose to digest.

Negative control uses a repressor:

1. The separate lacI gene constitutively produces the LacI repressor protein (a trans-acting factor).
2. With no lactose present, LacI binds the operator, physically blocking RNA polymerase. The operon is OFF — making lactose enzymes when there is no lactose would waste resources.
3. When lactose is present, some is converted to allolactose, the true inducer. Allolactose binds LacI (an allosteric change), LacI releases the operator, and RNA polymerase transcribes the structural genes. The operon turns ON.

This is "negative" control because the default action of the regulatory protein is to repress; the signal (allolactose) works by removing the repressor.

Operon map (no lactose, repressed):

Mechanistic note: Allolactose, not lactose itself, is the inducer. In the lab, the non-metabolizable mimic IPTG is used to induce the operon without being consumed — a detail that signals the inducer acts on LacI, not as a fuel.

The lac Operon II — Positive Control (CAP, cAMP, and the Glucose Effect)

Relieving repression is only half the story. Even with lactose present, the cell should prefer glucose if both are available — glucose is the easier fuel. This preference is enforced by positive control layered on top of the repressor.

The players:

• CAP (catabolite activator protein), a trans-acting activator.
• cAMP (cyclic AMP), a small-molecule signal whose level reports glucose scarcity. When glucose is low, cAMP is high; when glucose is high, cAMP is low.

The logic:

1. CAP can only bind its DNA site (just upstream of the promoter) when it is complexed with cAMP.
2. Bound CAP-cAMP recruits RNA polymerase, dramatically boosting transcription. Without it, the lac promoter is weak — polymerase binds poorly even when the operator is free.
3. When glucose is high, cAMP falls, CAP cannot bind, and transcription stays low even if lactose is present and the repressor is off.

This is catabolite repression (the "glucose effect"): the presence of glucose indirectly represses the lac operon by lowering cAMP. CAP is the textbook example of positive control — the regulatory protein's job is to activate, and the signal works by enabling it to bind.

AP trap: Catabolite repression is positive control (CAP is an activator), despite the misleading word "repression." The repression is of the operon's output and is achieved by withdrawing an activator, not by adding a repressor.

Putting It Together — The Four Conditions (Truth Table)

The lac operon integrates two inputs (is lactose present? is glucose present?) through two regulators (LacI repressor, CAP activator). Work through all four combinations:

Reading the table:

• No lactose ⇒ OFF, regardless of glucose. With no substrate, the repressor stays on the operator; there is nothing to induce. (Top two rows.)
• Lactose present ⇒ repressor off, but output now depends on glucose. With glucose still around (row 3), low cAMP means no CAP-cAMP, the weak promoter is barely used, and transcription is only LOW ("leaky"). With glucose gone (row 4), high cAMP lets CAP-cAMP supercharge the promoter, and transcription is HIGH.

Why glucose "wins": The cell wants maximal lac expression only in the one situation where it is truly advantageous — lactose available and glucose exhausted. Glucose, by suppressing cAMP, holds the operon at a low level until glucose runs out, even after the repressor has let go. Two independent switches (one negative, one positive) must both favor "on" to get full transcription.

One-line summary: Lactose flips the repressor switch; the absence of glucose flips the activator switch. Full HIGH expression requires both — lactose ON and glucose OFF.

Checkpoint — Predicting lac Operon Output

The trp Operon — Repressible Control and Attenuation

The trp operon encodes enzymes that synthesize the amino acid tryptophan. The logic is opposite to lac: a cell should make tryptophan-building enzymes only when tryptophan is scarce, and shut them off once enough has accumulated. So the trp operon is repressible — normally ON, switched OFF by its own end product.

Repression by a corepressor:

1. The trpR gene makes the trp repressor, but the repressor is inactive on its own and cannot bind the operator. So by default the operon is ON and tryptophan is synthesized.
2. When tryptophan is abundant, tryptophan acts as a corepressor: it binds the trp repressor, changing its shape so it can now bind the operator. The operon switches OFF.
3. This is feedback (end-product) repression — the product of the pathway shuts down its own production.

Inducible vs. repressible — side by side:

Attenuation (a second, finer layer in trp): beyond the on/off operator switch, E. coli uses attenuation to fine-tune output. Because transcription and translation are coupled, the speed of a ribosome translating a short leader peptide rich in Trp codons determines whether a terminator hairpin forms in the mRNA. When tryptophan (and thus charged tRNA-Trp) is plentiful, the ribosome moves fast, a terminator hairpin forms, and transcription stops early — adding extra dampening on top of repression. When Trp is scarce, the ribosome stalls, an antiterminator forms, and transcription proceeds.

AP trap: Repressible ≠ inducible. The trp operon is repressible (default ON, end product turns it OFF via a corepressor); the lac operon is inducible (default OFF, substrate turns it ON via an inducer). Both can use repressor proteins, but the repressor's default activity and the direction of the switch are opposite.

Exit Ticket — Operon Logic

Eukaryotic Regulation

Part 3 of 7

Eukaryotes face a regulatory challenge bacteria never do: building and maintaining hundreds of distinct cell types from one genome, over an organism's whole lifetime. Their solution is richer and more layered than the prokaryotic operon. Two architectural facts shape everything:

1. Eukaryotic genes are regulated individually, not in operons. Each gene has its own promoter and its own set of regulatory sequences. Genes in the same pathway are usually scattered across chromosomes and switched on by shared transcription factors, not by being strung together on one mRNA.
2. DNA is packaged into chromatin. Before a gene can even be read, its DNA must be made physically accessible. Chromatin state is the first gate.

AP trap (carry it forward): Operons are prokaryotic. A eukaryotic question that mentions "the operon for muscle genes" is wrong on its face. Eukaryotic coordination comes from common transcription factors acting on individually promoted genes.

Chromatin Structure — The First Gate

Eukaryotic DNA is wound around histone proteins to form nucleosomes, which fold into higher-order chromatin. How tightly the DNA is packed determines whether transcription machinery can reach it:

A gene buried in heterochromatin is effectively off no matter what activators are floating in the nucleus — the proteins cannot physically dock. Converting between states (via the chromatin-remodeling and histone-modifying enzymes detailed in Part 4) is therefore a master switch. This packaging layer has no equivalent in the lac operon, where the DNA is broadly open and regulation happens entirely at the operator/promoter.

Mechanistic link: Because access is gated by chromatin, a eukaryotic gene must be (1) made accessible and (2) bound by the right activators to be transcribed. Two conditions, not one — which is why eukaryotic control is described as multilayered.

Enhancers, Silencers, and Combinatorial Control

Once chromatin is open, transcription of a eukaryotic gene depends on proteins binding regulatory DNA — but those sequences can sit far from the gene.

• Enhancers are DNA elements (cis) that increase transcription, often located thousands of base pairs upstream, downstream, or even within introns. Activator proteins (trans) bind enhancers; the DNA loops so the bound activators contact the promoter machinery.
• Silencers are DNA elements (cis) that decrease transcription when bound by repressor proteins (trans).
• General (basal) transcription factors assemble at the promoter (around the TATA box) and position RNA polymerase II; they are required for any transcription but give only a low basal rate.
• The Mediator complex is the physical bridge: it relays signals from distant enhancer-bound activators to the general transcription factors and polymerase at the promoter.

Combinatorial control is the key eukaryotic principle: a typical gene is governed not by one switch but by a combination of many transcription factors binding many elements. A gene turns on only when the right set of activators is present together. This is powerful because a few hundred transcription factors, used in different combinations, can specify thousands of distinct gene-expression patterns — enough to define every cell type from one genome.

Cell-type specificity emerges from this: a liver cell and a neuron differ because each contains a different combination of active transcription factors, which switch on different enhancers, which turn on different gene sets.

Contrast with operons: Bacteria coordinate genes by physical linkage (one operon, one mRNA). Eukaryotes coordinate genes by shared trans-factors — the same activator binds enhancers near many separate genes, switching them on together without ever bundling them into one transcript.

Checkpoint — Chromatin & Combinatorial Control

Beyond Transcription — Splicing, Stability, and Localization

Transcription is only the first control point. Eukaryotes regulate the RNA itself, multiplying the output of a single gene.

Alternative splicing. A single pre-mRNA can be spliced in different ways, including or excluding particular exons, to produce multiple distinct proteins from one gene. This is a major reason humans make far more proteins than they have genes; it is also cell-type-specific, so a gene can yield one protein isoform in the brain and another in muscle.

mRNA stability. How long an mRNA survives before being degraded sets how many protein copies can be made from it. Sequences in the $3'$ UTR (and miRNA targeting — Part 5) control the rate of degradation. A long-lived mRNA yields far more protein than a short-lived one, even at equal transcription rates.

mRNA localization. Cells can transport specific mRNAs to particular regions and translate them only there, concentrating a protein exactly where it is needed (e.g., at one end of a developing embryo). This produces spatial control that transcription alone cannot.

A control-level map for eukaryotic regulation:

Big picture: Where bacteria mostly regulate at transcription, eukaryotes deploy a stack of control points — chromatin, transcription, splicing, stability, localization, translation, and protein modification. Each adds a tuning knob, and together they let one genome run an entire multicellular organism.

Worked Reasoning — How a Gene Reads a Combination of Factors

Combinatorial control is abstract until you trace it through a concrete gene. Consider a hypothetical "liver enzyme" gene whose enhancer has binding sites for three transcription factors — call them A, B, and R. A and B are activators; R is a repressor. The promoter is in open euchromatin in every cell type, so chromatin is not the limiting factor here — the deciding variable is which factors are present.

The gene fires strongly only when both activators are present and the repressor is absent. Predict the output across cell types, each defined by the factors it happens to express:

Read the logic:

• The gene is not controlled by any single switch. It integrates three inputs, and only the hepatocyte's particular combination ($A$ + $B$, no $R$) yields full expression.
• A few transcription factors, in different combinations, thus generate distinct outputs in different cells — the molecular basis of how one genome builds many cell types.
• This mirrors the lac operon's two-switch logic (Part 2), but eukaryotes scale it up to many factors per gene, and the factors are shared across many individually promoted genes.

Connecting to differentiation. A cell's identity is its set of active transcription factors. A "master regulator" factor that switches on a battery of muscle genes can, when introduced into a fibroblast, push it toward a muscle-like state — direct evidence that the combination of factors, not a change in the genome, specifies cell type.

Reasoning habit: For a eukaryotic gene, do not ask "is the switch on?" Ask "which combination of activators and repressors is present, and does the chromatin allow access?" Output is the integration of all those inputs — high, low, or off.

Exit Ticket — Eukaryotic Layers

Epigenetics

Part 4 of 7

How does a liver cell, when it divides, give rise to two liver cells rather than reverting to some generic state? Its daughters must "remember" which genes were on and off. That memory is epigenetic: heritable changes in gene expression that do not alter the DNA sequence itself.

The prefix epi- means "on top of." Epigenetic marks sit on top of the genome — chemical tags on DNA and on histones — and they are copied along when chromatin is replicated, so a cell's regulatory state persists through mitosis.

AP trap (bank it now): Epigenetic changes do NOT change the DNA sequence. If a question describes a heritable expression change with "no change in nucleotide sequence," the answer is epigenetic (methylation, histone modification, chromatin remodeling) — never mutation. A mutation changes the sequence; an epigenetic mark changes how the unchanged sequence is read.

DNA Methylation — Silencing by a Chemical Tag

The most studied epigenetic mark is DNA methylation: the addition of a methyl ($\text{CH}_3$) group to cytosine bases, carried out by DNA methyltransferase enzymes. In animals this happens mainly at CpG sites — a cytosine followed by a guanine.

• Clusters of CpG sites, called CpG islands, often sit in gene promoters.
• Heavy methylation of a promoter's CpG island silences the gene. The methyl tags both directly impede transcription-factor binding and recruit proteins that compact the surrounding chromatin into heterochromatin.
• Generally: more promoter methylation ⇒ less expression; unmethylated promoters tend to be active.

Because methylation patterns are copied after DNA replication (a "maintenance" methyltransferase re-methylates the new strand to match the old one), the silenced state is inherited by daughter cells through mitosis. This is the molecular basis of cellular memory — it is how differentiated cells stay differentiated.

Direction matters: Methylation of a promoter CpG island typically represses. Do not over-generalize "methylation = silencing" to every context, but for AP purposes, promoter CpG-island methylation → gene OFF is the canonical relationship.

Histone Modifications and Chromatin Remodeling

DNA is wrapped around histones; chemical tags on the histones' tails change how tightly the DNA is held, opening or closing access. Two of the most important, with opposite effects:

• Histone acetylation (adding acetyl groups, by histone acetyltransferases / HATs) loosens chromatin → euchromatin → activates transcription. Removing acetyl groups (by histone deacetylases / HDACs) tightens chromatin → represses.
• Histone methylation can either activate or repress depending on which residue is modified. Certain histone methylations (e.g., on specific lysines) recruit compacting proteins and repress; others mark active genes. For AP, the safe statement is: acetylation generally activates; some methylations repress.

Chromatin-remodeling complexes are ATP-driven machines that physically slide, eject, or restructure nucleosomes, exposing or hiding regulatory DNA. They work alongside the chemical marks to set chromatin state.

A "writer → effect" reference table (writers add marks; readers interpret them; erasers remove them):

Key idea: Acetylation and methylation/deacetylation push chromatin toward opposite poles. The combination of marks on a stretch of chromatin — sometimes called the "histone code" — is read out to determine whether the underlying genes are active or silent.

Checkpoint — Marks and Their Effects

Genomic Imprinting, X-Inactivation, and the Environment

Two classic phenomena show epigenetics in action — both produce stable expression differences with no change in DNA sequence.

Genomic imprinting. For a small set of genes, expression depends on the parent of origin: only the maternal or only the paternal copy is active, because the other was epigenetically silenced (typically by methylation) in the egg or sperm. Both alleles may be identical in sequence, yet one is "marked" off. The mark is reset and re-applied each generation in the germ line.

X-chromosome inactivation. In female mammals, one of the two X chromosomes in each cell is condensed into a transcriptionally silent Barr body early in development. This dosage-compensation mechanism is epigenetic: the inactivated X is heavily methylated and packed into heterochromatin. Crucially, the choice is clonally inherited — all descendants of a cell keep the same X inactive — producing patches of tissue expressing one X or the other (the basis of calico/tortoiseshell coat patterns).

Environment–epigenome link. Epigenetic marks can be influenced by the environment — diet, stress, and chemical exposures can alter methylation and histone modification patterns, changing gene expression without changing the genome. This provides a molecular route by which experience and environment leave lasting, sometimes heritable, marks on gene activity — a frequent context in modern AP free-response prompts.

Unifying point: Imprinting, X-inactivation, and environmental effects are all the same kind of thing: stable, heritable changes in which genes are expressed, achieved by chromatin marks rather than by editing the DNA letters.

Epigenetic vs. Genetic Change — The Distinction the Exam Tests

The single most tested idea in this part is the boundary between an epigenetic change and a genetic (mutational) change. They can produce the same loss of gene function, so the exam forces you to tell them apart from the evidence.

The decisive question: Did the nucleotide sequence change? If the stem says the sequence is intact but expression is heritably altered, the answer is epigenetic. If a base is substituted, inserted, or deleted, it is a mutation. This one fork resolves the majority of "is it epigenetic or genetic?" items.

Worked mini-example. Two patient samples each have a silenced tumor-suppressor gene.

• Sample 1: sequencing finds a premature stop codon in the gene. → Mutation (genetic); the protein is truncated/nonfunctional because the sequence changed.
• Sample 2: sequencing finds a perfectly normal gene, but the promoter CpG island is hypermethylated and histones are deacetylated. → Epigenetic silencing; the sequence is fine, but the gene is locked in heterochromatin and not transcribed.

Both samples lose the protein, yet only Sample 2 is reversible in principle — a drug that blocks methylation or inhibits HDACs could re-open the gene (the basis of several real epigenetic therapies). A mutation cannot be "un-read" that way.

Bank this phrasing: Epigenetic changes alter gene EXPRESSION, not gene SEQUENCE; they are heritable through cell division and are often reversible. Reproduce that sentence and the epigenetics traps in Parts 4 and 7 become easy points.

Exit Ticket — Epigenetic Inheritance

RNA Interference

Part 5 of 7

Not all gene regulation is done by proteins. Cells also use small RNA molecules to control which mRNAs get translated — a system called RNA interference (RNAi). Because these RNAs act after an mRNA is already made, RNAi is a form of post-transcriptional regulation: it does not stop transcription; it controls the fate of the transcript.

The two main players are microRNAs (miRNAs) and small interfering RNAs (siRNAs) — short (~21-23 nucleotide) RNAs that guide a protein complex to complementary mRNAs and shut them down. The discovery of RNAi reshaped our understanding of gene regulation and handed researchers a precise tool for switching genes off.

AP trap (bank it now): RNAi acts post-transcriptionally — on the mRNA, not the DNA. It does not change the DNA sequence and (in the AP-canonical view) does not block transcription itself; it degrades or silences transcripts that already exist.

Biogenesis — Where the Small RNAs Come From

Both miRNAs and siRNAs are processed from double-stranded RNA precursors and loaded into the same effector machinery, but their origins differ:

• miRNAs are encoded by the organism's own genome. They are transcribed as longer precursors that fold into hairpins, then trimmed by the enzyme Dicer into short double-stranded fragments.
• siRNAs typically derive from longer double-stranded RNA, often of viral or experimental (exogenous) origin, also diced by Dicer into short duplexes.

The shared downstream pathway:

1. Dicer cuts the precursor into a short (~21-23 nt) RNA duplex.
2. One strand (the guide strand) is loaded into RISC (the RNA-Induced Silencing Complex), whose catalytic core is an Argonaute protein. The other strand is discarded.
3. The guide RNA base-pairs with complementary sequences in target mRNAs, directing RISC to silence them.

One enzyme, one complex, two inputs: Remember the pipeline Dicer → RISC/Argonaute. Whether a small RNA came from your own genes (miRNA) or from outside (siRNA), it ends up steering the same silencing machine.

Mechanism — Degrade or Repress? It Depends on the Match

Once a guide RNA inside RISC finds a target mRNA, the degree of base-pairing complementarity determines the outcome:

• Extensive / perfect complementarity → Argonaute cleaves the mRNA, which is then degraded. The target is destroyed. (Typical of siRNAs.)
• Partial complementarity → RISC does not cut; instead it blocks translation and/or promotes mRNA destabilization, so the mRNA persists but is poorly translated. (Typical of many animal miRNAs binding the $3'$ UTR.)

Either way, the net effect is the same direction: less protein from the targeted gene. The two routes differ in how — destroying the message vs. silencing it — and in whether the mRNA disappears or merely goes quiet.

This makes RNAi a versatile dimmer switch. A single miRNA can have many target mRNAs (any transcript with a matching sequence), so one small RNA can coordinate the dampening of a whole set of genes — a counterpart to how one transcription factor regulates many genes.

Quantitative intuition (fold-change): If a miRNA represses its target to one-fourth of normal, that is roughly a $4\times$ drop, a fold-change of about $0.25$. Remove that miRNA and the target rebounds toward $1\times$. RNAi outcomes are usually described as relative changes in protein/mRNA level, not absolute on/off.

Checkpoint — Predicting RNAi Outcomes

RNAi as a Laboratory Tool — Targeted Knockdown

Because siRNAs silence whatever mRNA they match, researchers exploit RNAi to knock down a gene of interest on demand. The workflow:

1. Design a synthetic siRNA (or an expressed short-hairpin RNA) complementary to the target gene's mRNA.
2. Introduce it into cells. Dicer/RISC processing loads the guide strand into RISC.
3. RISC finds and silences the target mRNA, reducing the gene's protein output — without altering the genome.

This is a loss-of-function experiment: by lowering one protein and watching what changes, scientists infer that protein's normal role. Note the contrast with a true genetic knockout:

Because RNAi leaves the DNA untouched and usually produces a partial, dose-dependent reduction, it is ideal for asking "what happens when there is less of protein X?" while keeping the gene intact.

Connecting the unit: RNAi is a regulatory layer that the cell itself uses (miRNAs fine-tuning developmental genes) and that scientists borrow (siRNA knockdowns). In both cases the action is post-transcriptional — controlling the message after the gene has been read.

miRNA in the Cell vs. siRNA in the Lab — and Where RNAi Fits

It helps to separate the biological role of each small RNA from its experimental use, because AP questions probe both.

miRNA — an endogenous regulatory layer. The genome encodes hundreds of miRNAs. Each fine-tunes its targets, and because a miRNA needs only partial complementarity, one miRNA can dampen dozens of different mRNAs that share a short matching seed sequence. This makes miRNAs powerful coordinators of programs such as development and the cell cycle — a single miRNA can lower the output of a whole functional group of genes at once, the post-transcriptional counterpart to a transcription factor that activates many genes.

siRNA / RNAi as antiviral defense and as a tool. siRNAs often originate from double-stranded RNA, a molecular signature of viral replication. Dicing that dsRNA into siRNAs and silencing the matching (viral) mRNAs is a built-in antiviral defense in many organisms. Researchers co-opt the same pathway by introducing synthetic dsRNA/siRNA to knock down any chosen gene.

Placing RNAi among the regulatory levels (the whole unit on one axis):

RNAi occupies the post-transcriptional slot: the gene has been transcribed, the mRNA exists, and RNAi decides how much of it survives to be translated. That placement is exactly what distinguishes it from a repressor (which prevents the mRNA from being made) and from a phosphorylation event (which modifies a protein already made).

AP framing: If a question says a treatment "lowered the protein but the mRNA was destroyed and the DNA was unchanged," that is RNAi (post-transcriptional) — not transcriptional repression and not mutation. The destroyed-mRNA-plus-intact-DNA signature is the giveaway.

Exit Ticket — RNAi Reasoning

Problem-Solving Workshop — lac Operon Genetics

Part 6 of 7

The classic test of whether you understand the lac operon is to predict the behavior of mutants. AP and college genetics both lean on this. To solve these problems you need two ideas from Part 1, applied ruthlessly:

• cis vs. trans. A mutation in a cis-element (promoter, operator) affects only the operon physically attached to it on the same DNA molecule. A mutation in a trans-factor's gene (lacI repressor) makes a diffusible protein that affects every lac operator in the cell.
• Dominance in partial diploids. A merodiploid (partial diploid) carries two copies of the lac region — one on the chromosome and one on an F$'$ plasmid. We write the genotype as chromosome / F$'$. Comparing the two copies reveals whether a mutation is dominant or recessive, and whether it acts in cis or trans.

The readout in every problem is $\beta$-galactosidase (the lacZ product): is it made with inducer, without inducer, or never?

The mutant alphabet:

Golden rule: Operator and promoter mutations are cis — they govern only the genes downstream on the same DNA molecule. Repressor mutations are trans — the protein floats and acts on both operons in a merodiploid. Keep asking: "Is this element a sequence on the DNA (cis) or a diffusible protein (trans)?"

Worked Problem 1 — A Repressor Mutation ($I^-$) and Its Rescue

Setup. Consider the haploid genotype $I^-\;O^+\;Z^+$. Predict $\beta$-galactosidase production with and without inducer.

Reason it through.

• $I^-$ means no functional repressor is made. With nothing to bind the operator, RNA polymerase transcribes lacZ regardless of inducer.
• Result: $\beta$-gal is made constitutively — present both with and without inducer. The operon has lost its "off" switch.

Now make a partial diploid to ask whether $I^-$ is dominant or recessive. Genotype: $I^-\;O^+\;Z^+ \;/\; I^+\;O^+\;Z^+$ (chromosome / F$'$).

• The $I^+$ copy on one DNA molecule makes a functional repressor protein. Because the repressor is a trans-acting diffusible protein, it spreads through the cell and can bind both operators — the one next to $I^-$ and the one next to $I^+$.
• So both copies are now normally regulated: off without inducer, on with inducer.
• Conclusion: $I^+$ is dominant to $I^-$; $I^-$ is recessive. This is the hallmark of a trans element — a good copy anywhere in the cell rescues the bad copy. The functional repressor does not care which DNA molecule it came from.

Take-away: A recessive defect that is rescued by a good copy on the other DNA molecule proves the gene acts in trans (it makes a diffusible product). $I^-$ passes this test.

Worked Problem 2 — The Operator-Constitutive Mutation ($O^c$) Acts Only in Cis

Setup. Genotype: $I^+\;O^c\;Z^+$ (haploid). The operator is mutated so the repressor cannot bind it.

Reason it through.

• Even though a perfectly good repressor ($I^+$) is present, it has no operator to grip. lacZ is transcribed constitutively — $\beta$-gal with and without inducer.
• Note this looks like the $I^-$ phenotype (constitutive), but the cause is different: a broken cis site, not a missing trans protein.

The decisive partial diploid. Arrange the mutation and the reporter carefully — genotype $I^+\;O^c\;Z^+ \;/\; I^+\;O^+\;Z^-$ (chromosome / F$'$):

Here the $O^c$ operator sits next to a functional $Z^+$; the normal $O^+$ operator sits next to a broken $Z^-$. Predict each operon's lacZ output:

• The functional $\beta$-gal comes only from the molecule carrying $O^c$, and it is constitutive. The good repressor in the cell cannot fix it, because the operator defect affects only the genes physically attached to it.
• Conclusion: $O^c$ is cis-dominant (also called cis-acting). It controls only its own operon, and no trans-factor can rescue it.

Contrast the two constitutive mutants:

The key experiment: Putting $O^c$ next to $Z^+$ but $O^+$ next to $Z^-$ forces each operon to "report" separately. Constitutive enzyme tracking with the $O^c$ copy proves the operator acts in cis. This cis/trans test is the single most important reasoning pattern in operon genetics.

Worked Problem 3 — The Super-Repressor ($I^s$) Is Trans AND Dominant

Setup. $I^s$ encodes a repressor that cannot bind inducer. It clamps onto the operator and never lets go, even when lactose/allolactose is present.

Haploid $I^s\;O^+\;Z^+$: the operon is permanently OFF — no $\beta$-gal with or without inducer, because the inducer can no longer pry the repressor off.

Partial diploid $I^s\;O^+\;Z^+ \;/\; I^+\;O^+\;Z^+$:

• The cell contains both the mutant $I^s$ repressor and the normal $I^+$ repressor. The $I^s$ protein is diffusible (trans) and binds both operators, shutting them down regardless of the normal repressor.
• Even with inducer present, the $I^s$ molecules keep clamping operators faster than they release, so both operons stay off.
• Conclusion: $I^s$ is dominant and trans-acting — the defective protein imposes its phenotype on the whole cell. (Contrast with $I^-$, which is recessive because the absence of a protein is rescued by a good copy.)

A summary of all the lac genotypes you should be able to predict cold:

Decision recipe for any lac mutant: (1) Is the repressor functional and inducible? ($I^+$ yes; $I^-$ none; $I^s$ stuck on). (2) Can that repressor reach this operator? (Only if the operator is $O^+$ — an $O^c$ blocks it for its own operon only). (3) Is the promoter intact and is $Z$ functional? Walk these in order and the phenotype falls out.

Worked Problem 4 — A Promoter Mutation ($P^-$) Is Cis and Silences Its Own Operon

A promoter mutation, $P^-$, prevents RNA polymerase from binding. Because the promoter is a cis element, it affects only the operon on its own DNA molecule — and the effect is the opposite of $O^c$: instead of being stuck on, the operon is stuck off.

Haploid $I^+\;P^-\;O^+\;Z^+$: no polymerase can load, so no $\beta$-gal is ever made, with or without inducer. Note this mimics the $I^s$ phenotype (always off) but for a completely different reason — a broken cis promoter, not a stuck trans repressor.

Decisive partial diploid $I^+\;P^-\;O^+\;Z^+ \;/\; I^+\;P^+\;O^+\;Z^-$ (chromosome / F$'$):

• The good $P^+$ on the plasmid cannot rescue the chromosomal $Z^+$, because a promoter only serves the genes physically attached to it. The functional $Z^+$ has a dead promoter; the working promoter sits over a dead $Z^-$.
• Result: essentially no functional $\beta$-gal, inducer or not. $P^-$ is cis-acting, just like $O^c$ — but it locks the operon OFF rather than ON.

The cis/trans grand summary (memorize the pattern, not just the rows):

Pattern to extract: The two cis mutations ($O^c$, $P^-$) can never be rescued in trans and act only locally. The two trans mutations ($I^-$, $I^s$) act cell-wide; whether a good copy rescues them depends on whether the defect is an absence ($I^-$, recessive, rescuable) or a dominant poison ($I^s$, not rescuable).

Checkpoint — Predict the Mutant Phenotype

AP Review — Gene Regulation Synthesis

Part 7 of 7

You now have the full toolkit: levels of control (Part 1), prokaryotic operons (Part 2), eukaryotic chromatin and combinatorial control (Part 3), epigenetics (Part 4), RNA interference (Part 5), and operon-mutant genetics (Part 6). This part stitches them into the few load-bearing ideas the AP exam tests over and over, then drills the application reasoning.

The unifying thesis: All cells of an organism share one genome; differential gene expression — regulating which genes are on and how much — produces cell types, responses to the environment, and development. Regulation can act at any step from DNA to functional protein, and the cell chooses the step that fits the job.

The High-Yield AP Traps (Memorize These)

Most missed gene-regulation questions come from a handful of predictable confusions. Pre-load the corrections:

1. Operons are PROKARYOTIC. Eukaryotic genes are regulated individually and coordinated by shared transcription factors, not bundled into operons. Any "eukaryotic operon" in a stem is a red flag.

2. Repressible ≠ inducible.

   • Inducible (lac): default OFF, a substrate-derived inducer turns it ON by removing the repressor.
   • Repressible (trp): default ON, an end-product corepressor turns it OFF by activating the repressor.

3. CAP is POSITIVE control. Catabolite repression sounds negative, but CAP is an activator; "repression" by glucose works by lowering cAMP and withdrawing the CAP activator, not by adding a repressor. Glucose LOWERS cAMP (high glucose → low cAMP → no CAP binding).

4. Full lac expression needs BOTH switches. Lactose present (repressor off) and glucose absent (CAP-cAMP on). Lactose alone with glucose present gives only LOW output.

5. Epigenetic changes do NOT alter the DNA sequence. Methylation, histone modification, and chromatin remodeling change how genes are read, are heritable through mitosis, yet leave the nucleotide sequence intact. Do not call them mutations.

6. RNAi acts POST-TRANSCRIPTIONALLY. miRNAs/siRNAs target mRNA (cleavage or translational repression) in the cytoplasm; they do not change DNA and (canonically) do not block transcription. More repressing miRNA → less protein; remove it → more protein.

7. Cis vs. trans. A cis defect (operator $O^c$, promoter $P^-$) affects only the operon on its own DNA molecule and cannot be rescued in trans. A trans defect (repressor $I^-$, $I^s$) involves a diffusible protein that affects all target operons in the cell.

Exam tactic: When two answers look plausible, pick the one that names a specific mechanism and states the direction of the effect (on vs. off, more vs. less protein). Vague "it regulates the gene" answers are usually distractors.

Reading Experiments — The Skill the FRQs Reward

AP free-response and data questions almost always hand you an experiment and ask which level of regulation is involved or what a mutant predicts. Two reasoning templates carry most of the load.

Template A — "Which level?" Use the assay to localize the control point:

Template B — "What does the mutant predict?" Walk the cis/trans checklist (from Part 6): Is the repressor functional and inducible? Can it reach this operator (only if $O^+$)? Is the promoter intact and the reporter gene functional? In a partial diploid, remember a good trans product (repressor) rescues both operons, while a cis defect (operator/promoter) is confined to its own molecule.

Putting them together — a model answer shape: "Because [signal] acts on [specific molecule], the cell regulates [gene] at the [level] step; therefore I predict [more/less] [mRNA/protein], which the data confirm by [assay result]." Naming the molecule, the level, and the direction is what earns the points.

Synthesis: Prokaryotes and eukaryotes share the logic — read a signal, set gene output — but differ in architecture (operons + coupled transcription/translation vs. chromatin + combinatorial TFs + RNA processing + RNAi + epigenetics). Master the cis/trans and inducible/repressible distinctions, keep the "no sequence change" and "post-transcriptional" flags handy, and the unit's questions become predictable.

Rapid-Fire Compare-and-Contrast (Exam Cram)

The exam loves to juxtapose two things that students blur together. Run these side-by-sides until each distinction is automatic.

1. lac vs. trp operon

2. Negative vs. positive control (within lac)

3. cis vs. trans (operon mutants)

4. Epigenetic vs. genetic change

5. miRNA/siRNA (RNAi) vs. a transcriptional repressor

Last word: Almost every gene-regulation question reduces to placing a mechanism in one of these grids and stating the direction of its effect. If you can fill these five tables from memory, you can reason through the unit's traps cold.

AP-Style Application — Synthesis